Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1298 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Hospira Topotecan Injection

Hospira, which expects to launch the product by the end of February, said topotecan 4 mg/4 ml is designed to improve caregiver convenience and safety. Hospira US president

Nitto Denko takes over Avecia Biotechnology

Besides cGMP (current good manufacturing practices) manufacturing, Avecia Biotechnology ‘s services also include the development of analytical methods, process validation, stability studies, quality control, and regulatory support for

Takeda nine-month profit declines

Further, the stronger Japanese currency has also eaten into the value of overseas revenue. Takeda‘s net income dropped to JPY215.5bn from JPY259.1bn year earlier. Sales fell 4.2% to